# MAGEB2

## Overview
MAGEB2 is a gene that encodes the protein MAGE family member B2, which is part of the melanoma antigen (MAGE) family. This family is characterized by a conserved MAGE homology domain (MHD), which plays a crucial role in the protein's function, although the specific mechanisms remain to be fully elucidated (Li2021Pathogenicity; Barker2002The). MAGEB2 is primarily expressed in the testis and is involved in translational repression, particularly by inhibiting the translation of the G3BP protein, a key player in stress granule formation (Lee2020Enhanced). Unlike other MAGE proteins that typically regulate ubiquitination, MAGEB2 functions as a translational repressor, highlighting its unique role within the family (Lee2020Enhanced). The protein is implicated in various cellular processes, including cell cycle progression and stress response, and has been associated with several diseases, such as cancer and autoimmune disorders, due to its altered expression and interactions (Peche2015Human; Pattani2012MAGEB2).

## Structure
The MAGEB2 protein is a member of the melanoma antigen (MAGE) family, characterized by a conserved MAGE homology domain (MHD) that is approximately 170 amino acids long. This domain is crucial for the protein's function, although its specific role remains uncertain (Li2021Pathogenicity; Barker2002The). The MHD is predicted to contain four potential α-helical domains and five β-sheet regions, suggesting a complex secondary structure (Barker2002The).

MAGEB2 is known to function as a translational repressor, specifically inhibiting the translation of the G3BP protein, a key stress granule nucleator. This function is distinct from other MAGE proteins, which typically regulate ubiquitination (Lee2020Enhanced). The protein's mechanism involves an RNA recognition motif in its N-terminal region, which may contribute to its role in translational regulation (Lee2020Enhanced).

The expression of MAGEB2 is testis-specific, and it plays a significant role in protecting the male germline from heat stress by modulating stress granule dynamics (Lee2020Enhanced). However, detailed information about the tertiary and quaternary structures of MAGEB2 is not provided in the available sources.

## Function
MAGEB2 is a protein that plays a significant role in cell biology by enhancing E2F transcriptional activity, which is crucial for cell cycle progression. It achieves this by interacting with HDAC1, a histone deacetylase that typically represses E2F1 activity. MAGEB2 disrupts the E2F1-HDAC1 interaction, leading to increased E2F1 activity and promoting cell proliferation (Peche2015Human; Van2017Oncogenic). This interaction is similar to other oncoproteins like LEF1 and HMGA2, which also enhance E2F activity (Peche2015Human).

MAGEB2 is localized in various cellular compartments, including the nucleus, cytoplasm, and nucleoli. Its nucleolar localization is dependent on a nucleolar localization signal (NoLS) sequence at its N-terminus. Under ribotoxic stress, MAGEB2 exits the nucleoli but continues to enhance E2F1 activity, indicating that its function is not significantly affected by its localization (Peche2015Human).

MAGEB2 also plays a role in conferring resistance to ribotoxic stress by impairing cell cycle arrest, which is associated with reduced cytostatic effects under such conditions (Peche2015Human). This ability to enhance E2F1 activity and promote cell cycle progression highlights MAGEB2's role in regulating cell proliferation and stress response.

## Clinical Significance
MAGEB2 has been implicated in several diseases and conditions due to alterations in its expression and interactions. In head and neck squamous cell carcinoma (HNSCC), MAGEB2 is activated through promoter demethylation, leading to its overexpression in tumor tissues compared to normal mucosa. This suggests its potential role as a proto-oncogene and a target for cancer vaccine therapy (Pattani2012MAGEB2). MAGEB2 is also associated with hepatocellular carcinoma (HCC), where it is significantly up-regulated in cancerous tissues. Its dysregulation correlates with clinical stage and prognosis, indicating its potential as a biomarker for diagnosis and treatment (Li2020A).

In autoimmune polyendocrine syndrome type 1 (APS1), MAGEB2 autoantibodies are detected in a significant portion of patients, suggesting its role as an immune target. This association raises questions about its involvement in infertility linked to APS1, as MAGEB2 is expressed in germ cells (Landegren2016Proteomewide). Additionally, MAGEB2 is implicated in systemic lupus erythematosus (SLE), where its expression can lead to autoimmune responses (Florke2020Emerging). These findings highlight the clinical significance of MAGEB2 in various diseases, particularly in cancer and autoimmune disorders.


## References


1. (Lee2020Enhanced) Enhanced stress tolerance through reduction of G3BP and suppression of stress granules. This article has 0 citations.

[2. (Li2021Pathogenicity) Sanyan Li, Xiang Shi, Jingping Li, and Xianrong Zhou. Pathogenicity of the mage family (review). Oncology Letters, October 2021. URL: http://dx.doi.org/10.3892/ol.2021.13105, doi:10.3892/ol.2021.13105. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.13105)

[3. (Barker2002The) Philip A. Barker and Amir Salehi. The mage proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. Journal of Neuroscience Research, 67(6):705–712, February 2002. URL: http://dx.doi.org/10.1002/jnr.10160, doi:10.1002/jnr.10160. This article has 243 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.10160)

[4. (Pattani2012MAGEB2) Kavita M. Pattani, Ethan Soudry, Chad A. Glazer, Michael F. Ochs, Hao Wang, Juliana Schussel, Wenyue Sun, Patrick Hennessey, Wojciech Mydlarz, Myriam Loyo, Semra Demokan, Ian M. Smith, and Joseph A. Califano. Mageb2 is activated by promoter demethylation in head and neck squamous cell carcinoma. PLoS ONE, 7(9):e45534, September 2012. URL: http://dx.doi.org/10.1371/journal.pone.0045534, doi:10.1371/journal.pone.0045534. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0045534)

[5. (Florke2020Emerging) Rebecca R. Florke Gee, Helen Chen, Anna K. Lee, Christina A. Daly, Benjamin A. Wilander, Klementina Fon Tacer, and Patrick Ryan Potts. Emerging roles of the mage protein family in stress response pathways. Journal of Biological Chemistry, 295(47):16121–16155, November 2020. URL: http://dx.doi.org/10.1074/jbc.rev120.008029, doi:10.1074/jbc.rev120.008029. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.rev120.008029)

[6. (Landegren2016Proteomewide) Nils Landegren, Donald Sharon, Eva Freyhult, Åsa Hallgren, Daniel Eriksson, Per-Henrik Edqvist, Sophie Bensing, Jeanette Wahlberg, Lawrence M. Nelson, Jan Gustafsson, Eystein S. Husebye, Mark S. Anderson, Michael Snyder, and Olle Kämpe. Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. Scientific Reports, February 2016. URL: http://dx.doi.org/10.1038/srep20104, doi:10.1038/srep20104. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep20104)

[7. (Li2020A) Rong Li, Jiao Gong, Cuicui Xiao, Shuguang Zhu, Zhongying Hu, Jinliang Liang, Xuejiao Li, Xijing Yan, Xijian Zhang, Danyang Li, Wei Liu, Yutian Chong, and Yusheng Jie. A comprehensive analysis of the mage family as prognostic and diagnostic markers for hepatocellular carcinoma. Genomics, 112(6):5101–5114, November 2020. URL: http://dx.doi.org/10.1016/j.ygeno.2020.09.026, doi:10.1016/j.ygeno.2020.09.026. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2020.09.026)

[8. (Van2017Oncogenic) Aurélie Van Tongelen, Axelle Loriot, and Charles De Smet. Oncogenic roles of dna hypomethylation through the activation of cancer-germline genes. Cancer Letters, 396:130–137, June 2017. URL: http://dx.doi.org/10.1016/j.canlet.2017.03.029, doi:10.1016/j.canlet.2017.03.029. This article has 143 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2017.03.029)

[9. (Peche2015Human) Leticia Y. Peche, María F. Ladelfa, María F. Toledo, Miguel Mano, Julieta E. Laiseca, Claudio Schneider, and Martín Monte. Human mageb2 protein expression enhances e2f transcriptional activity, cell proliferation, and resistance to ribotoxic stress. Journal of Biological Chemistry, 290(49):29652–29662, December 2015. URL: http://dx.doi.org/10.1074/jbc.m115.671982, doi:10.1074/jbc.m115.671982. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m115.671982)